Gus G. Emmick, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 20 Chambers Dr Ste 2200, Hooksett, NH 03106 Phone: 603-641-5386 Fax: 603-641-5387 |
News Archive
Want to be more productive and happier during the workday? Try taking a short break to text a friend, play "Angry Birds" or check Facebook on your smartphone, according to Kansas State University research.
A $235 million expansion of Australia's largest biotech facility in Melbourne is planned and this is expected to create hundreds of jobs. CSL biopharmaceutical research complex in Broadmeadows, in the north of Melbourne will be receiving this financial aid from both the State as well as Federal government over a five year investment plan. This will create an estimated 320 temporary construction jobs and later 333 new highly-skilled medical research openings by 2018.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
New research on the bed bug's ability to withstand the genetic bottleneck of inbreeding, announced today at the American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting, provides new clues to explain the rapidly growing problem of bed bugs across the United States and globally. After mostly disappearing in the US in the 1950s, the common bed bug (Cimex lectularius) has reappeared with a vengeance over the past decade. These stubborn pests have developed a resistance to the insecticides, known as pyrethroids, commonly used against them.
Results from the first prospective study of minimally invasive facet arthrodesis and long-term data on spinal cord stimulation demonstrate the viability of these options to achieve pain relief in patients with various back pain conditions. The studies were presented today at the American Academy of Pain Medicine's 26th Annual Meeting in San Antonio, TX.
› Verified 3 days ago